72.61万总市值-0.02市盈率TTM 0.000最高价0.000最低价0股成交量0.000今开0.008昨收0.00成交额0.00%换手率亏损市盈率(静)9076.11万总股本0.00852周最高-0.02市净率71.59万流通值0.00852周最低--股息TTM8948.50万流通股104.000历史最高--股息率TTM0.00%振幅0.008历史最低--平均价1股每手 ...
Infinity(R)燃料电芯和氢公司,提供了专为未来太空飞行任务设计的7千瓦氢氧燃料电芯 2024年10月14日,位于康涅狄格州温莎的Infinity Fuel Cell and Hydrogen, Inc.今天宣布已经发运第二批可用于太空飞行的质子交换膜(PEM)氢燃料电池。 Accesswire10/14 18:00 行业更新:医疗保健 周三下午晚些时候,医疗保健股走低,纽约...
Get the latest Infinity Pharmaceuticals Inc. (INFI) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
Three execs leave Infinity Pharmaceuticals after failed merger, layoffs - The Business Journals Financial Analysis Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.Underperform ...
Markets change, but our community always has the latest news, in-depth analysis, and powerful stock ratings. Create Free Account INFIQInfinity Pharmaceuticals, Inc. Growth Rates Follow8.68K followers $0.0000010.00 (0.00%)8:00 AM 12/24/24 ...
Infinity Pharmaceuticals stock price, live market quote, shares value, historical data, intraday chart, earnings per share and news.
You can view the fullInfinity Pharmaceuticals Ratings Report. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners.Click here to see his holdings for 14-days FREE. ...
Here we look at how a stock is currently valued compared to the rest of the market. The Value Score ranks each stock on a scale of 1 to 10 with 10 being the best. Based on backtesting results, the Value Score has been a very strong predictor of performance with higher scoring stocks...
called gravity causes an apple to fall to the ground from a tree, doesn't mean that gravity exists. whether or not issac newton ever existed to explain this idea to us, the apple would have fallen to the ground from the tree. jul. 24, 2018 7:19 pm view galmed pharmaceuticals: high...
Timothy Thein, analyst at Citigroup Inc. is upgrading both Ball and Rexam to buy from hold. Roth Capital analyst Andrew Vaino notes Infinity Pharmaceuticals Inc. and partner AstraZeneca PLC are in a deal returning full control of Retaspimycin....